Nutriband Inc. (NTRB)Healthcare | Biotechnology | Orlando, United States | NasdaqCM
2.94 USD
-0.07
(-2.326%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 3.00 +0.06 (2.041%) ⇧ (July 13, 2026, 6:13 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 5:18 a.m. EDT
The immediate outlook is bearish due to a confluence of deteriorating fundamentals and weak technical momentum. While the stock recently rallied 27% in a single week, this move is insufficient to overcome the reality that the company is burning significant cash, reporting negative operating margins, and shrinking its top line by over 35%. The balance sheet shows negative free cash flow and negative returns on equity, indicating a business that is consuming capital rather than generating it. Technically, the price is trading well below both its 50-day and 200-day averages, suggesting the recent pop was a temporary relief rally rather than a trend reversal. With no analyst coverage to provide a safety net and a massive gap between the current price and the consensus target, the near-term path appears fraught with downside risk as the market digests the operational struggles. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.086326 |
| MSTL | 0.092628 |
| AutoARIMA | 0.092645 |
| AutoETS | 0.092647 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 30% |
| H-stat | 11.75 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.565 |
| Excess Kurtosis | -0.41 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 3.885 |
| Revenue per Share | 0.151 |
| Market Cap | 35,738,592 |
| Forward P/E | -12.78 |
| Beta | 1.94 |
| Website | https://www.nutriband.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.6318408 |
| Address1 | 121 South Orange Avenue |
| Address2 | Suite 1500 |
| All Time High | 11.78 |
| All Time Low | 1.53 |
| Ask | 3.82 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 14,520 |
| Average Daily Volume3 Month | 11,227 |
| Average Volume | 11,227 |
| Average Volume10Days | 14,520 |
| Beta | 1.939 |
| Bid | 2.15 |
| Bid Size | 2 |
| Book Value | 0.493 |
| City | Orlando |
| Compensation As Of Epoch Date | 1,798,675,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.94 |
| Current Ratio | 5.259 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 2.9815 |
| Day Low | 2.94 |
| Debt To Equity | 3.885 |
| Display Name | Nutriband |
| Dividend Date | 1,563,926,400 |
| Earnings Timestamp End | 1,757,102,400 |
| Earnings Timestamp Start | 1,756,756,800 |
| Ebitda | -7,988,321 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -4.002 |
| Enterprise To Revenue | 17.734 |
| Enterprise Value | 31,968,130 |
| Eps Forward | -0.23 |
| Eps Trailing Twelve Months | -2.56 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.428 |
| Fifty Day Average Change | -0.48799992 |
| Fifty Day Average Change Percent | -0.14235704 |
| Fifty Two Week Change Percent | -63.184082 |
| Fifty Two Week High | 9.207 |
| Fifty Two Week High Change | -6.2669997 |
| Fifty Two Week High Change Percent | -0.6806777 |
| Fifty Two Week Low | 2.9 |
| Fifty Two Week Low Change | 0.03999996 |
| Fifty Two Week Low Change Percent | 0.013793089 |
| Fifty Two Week Range | 2.9 - 9.207 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,633,095,000,000 |
| Float Shares | 5,280,073 |
| Forward Eps | -0.23 |
| Forward P E | -12.782609 |
| Free Cashflow | -1,724,272 |
| Full Exchange Name | NasdaqCM |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.28355 |
| Gross Profits | 511,128 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.56814 |
| Held Percent Institutions | 0.03081 |
| Implied Shares Outstanding | 12,155,983 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,021-10-01 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,769,817,600 |
| Last Split Date | 1,660,262,400 |
| Last Split Factor | 1,166:1000 |
| Long Business Summary | Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida. |
| Long Name | Nutriband Inc. |
| Market | us_market |
| Market Cap | 35,738,592 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_345353860 |
| Most Recent Quarter | 1,777,507,200 |
| Net Income To Common | -29,896,884 |
| Next Fiscal Year End | 1,801,353,600 |
| Non Diluted Market Cap | 35,981,709 |
| Number Of Analyst Opinions | 1 |
| Open | 2.96 |
| Operating Cashflow | -4,360,762 |
| Operating Margins | -2.8942199 |
| Payout Ratio | 0.0 |
| Phone | 407 377 6695 |
| Post Market Change | 0.059999943 |
| Post Market Change Percent | 2.0408144 |
| Post Market Price | 3.0 |
| Post Market Time | 1,783,980,797 |
| Previous Close | 3.01 |
| Price Hint | 4 |
| Price To Book | 5.963489 |
| Price To Sales Trailing12 Months | 19.825937 |
| Profit Margins | 0.0 |
| Quick Ratio | 4.817 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.06999993 |
| Regular Market Change Percent | -2.3255792 |
| Regular Market Day High | 2.9815 |
| Regular Market Day Low | 2.94 |
| Regular Market Day Range | 2.94 - 2.9815 |
| Regular Market Open | 2.96 |
| Regular Market Previous Close | 3.01 |
| Regular Market Price | 2.94 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 6,768 |
| Return On Assets | -0.78183 |
| Return On Equity | -1.45722 |
| Revenue Growth | -0.351 |
| Revenue Per Share | 0.151 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 12,155,983 |
| Shares Percent Shares Out | 0.0126 |
| Shares Short | 153,051 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 172,289 |
| Short Name | Nutriband Inc. |
| Short Percent Of Float | 0.0292 |
| Short Ratio | 12.1 |
| Source Interval | 15 |
| State | FL |
| Symbol | NTRB |
| Target High Price | 15.0 |
| Target Low Price | 15.0 |
| Target Mean Price | 15.0 |
| Target Median Price | 15.0 |
| Total Cash | 4,006,184 |
| Total Cash Per Share | 0.33 |
| Total Debt | 232,714 |
| Total Revenue | 1,802,618 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.56 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 4.63473 |
| Two Hundred Day Average Change | -1.6947298 |
| Two Hundred Day Average Change Percent | -0.36565882 |
| Type Disp | Equity |
| Volume | 6,768 |
| Website | https://www.nutriband.com |
| Zip | 32,801 |